Sam Eiber
Stock Analyst at BTIG
(2.12)
# 3,054
Out of 4,356 analysts
49
Total ratings
39.3%
Success rate
1.4%
Average return
Main Sectors:
Stocks Rated by Sam Eiber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AIRS AirSculpt Technologies | Maintained: Hold | n/a | $5.38 | - | 5 | May 18, 2026 | |
| SBC SBC Medical Group Holdings | Maintained: Buy | $8 | $3.21 | +149.22% | 2 | May 14, 2026 | |
| ESTA Establishment Labs Holdings | Maintained: Buy | $88 → $90 | $70.69 | +27.32% | 11 | May 7, 2026 | |
| EOLS Evolus | Reiterated: Buy | $13 | $6.56 | +98.17% | 10 | May 5, 2026 | |
| MMSI Merit Medical Systems | Reiterated: Buy | $100 | $63.06 | +58.58% | 5 | May 1, 2026 | |
| APYX Apyx Medical | Upgraded: Buy | $6 | $4.00 | +50.19% | 7 | Mar 11, 2026 | |
| INMD InMode | Maintained: Hold | n/a | $13.93 | - | 9 | Feb 18, 2026 |
AirSculpt Technologies
May 18, 2026
Maintained: Hold
Price Target: n/a
Current: $5.38
Upside: -
SBC Medical Group Holdings
May 14, 2026
Maintained: Buy
Price Target: $8
Current: $3.21
Upside: +149.22%
Establishment Labs Holdings
May 7, 2026
Maintained: Buy
Price Target: $88 → $90
Current: $70.69
Upside: +27.32%
Evolus
May 5, 2026
Reiterated: Buy
Price Target: $13
Current: $6.56
Upside: +98.17%
Merit Medical Systems
May 1, 2026
Reiterated: Buy
Price Target: $100
Current: $63.06
Upside: +58.58%
Apyx Medical
Mar 11, 2026
Upgraded: Buy
Price Target: $6
Current: $4.00
Upside: +50.19%
InMode
Feb 18, 2026
Maintained: Hold
Price Target: n/a
Current: $13.93
Upside: -